DOW (DOW) Financials

Below is a concise, four-year trend assessment of DOW INC. (NYSE: DOW) using the provided quarterly income statements, cash flow statements, and balance sheets. The focus is on the last four years of data available and highlights the main drivers that retail investors often monitor: profitability, cash flow, liquidity, and leverage.

• Positive quarterly profitability: In Q3 2025, Net Income Attributable to Common Shareholders was about $62 million, marking a return to quarterly profitability after several prior quarters of losses.
• Strong cash flow from operations in late 2025: Net Cash From Continuing Operating Activities was about $1.13 billion in Q3 2025 and approximately $0.30 billion in Q4 2025, indicating improving cash-generation momentum in the second half of 2025 (relative to mid-year results).
• Solid near-term liquidity: Cash and equivalents were around $4.61 billion by Q3 2025, up from roughly $1.46 billion in Q1 2025, suggesting improved liquidity during 2025.
• Revenue stability in the 2023–2025 window: Operating revenue hovered near the $9.5–$10.5 billion range across 2024–2025 quarters, signaling steady top-line demand despite quarterly fluctuations.
• Balanced asset base with a sizable equity cushion: Total assets around $60–61 billion in 2025 quarters, and total equity in the upper teens to around $19 billion, indicating a relatively large asset base with a solid equity cushion.
• Moderate current liquidity indicators: Total current assets typically around $17–20 billion and total current liabilities around $10–11 billion in recent quarters, implying positive working capital but varying liquidity needs by quarter.
• Moderate gross margin in recent years: Gross profit in the 2024–2025 period typically represented roughly 5–7% of revenue, reflecting a modest gross margin environment for a diversified chemical materials company.
• Debt and leverage baseline: Long-term debt hovered around $14–18 billion and total liabilities typically around $38–42 billion in 2023–2025, indicating a meaningful but traditional corporate debt load for a manufacturing conglomerate.
• Material near-term impairment of profitability in Q4 2025: Total Operating Income for Q4 2025 was negative, at about -$1.04 billion, driven by high operating costs and a large restructuring charge.
• Restructuring and one-time charges in Q4 2025: Restructuring Charge totaling about $1.034 billion occurred in Q4 2025, contributing to a slide in quarterly earnings and pressuring margins.

Key takeaways for investors:

• Profitability has been uneven across quarters, with periods of income and times of loss. The positive quarterly net income in Q3 2025 suggests resiliency, but Q4 2025 showed a sizable net loss to common shareholders.
• Operating cash flow remained a meaningful driver of liquidity in late 2025, but quarterly CFO varied, including a negative reading in Q2 2025. This implies some cyclicality in cash generation tied to working capital and seasonal factors.
• The balance sheet remains large and asset-rich, with a solid equity base, but leverage remains sizable due to long-term debt and liabilities. Ongoing monitoring of debt maturities and interest expense is prudent.
• Capital expenditures in 2024–2025 have been material (typical for a manufacturing/chemicals company), affecting free cash flow in the near term, even as cash from operations supports liquidity.

Note: All figures are shown in USD and reflect reported or calculated values as provided in the JSON data for quarterly periods from 2021 through 2025, with emphasis on the latest four quarters (Q1–Q4 2025) and relevant prior-year periods for context.